142 related articles for article (PubMed ID: 35469741)
1. Prostate Volume Changes during Extreme and Moderately Hypofractionated Magnetic Resonance Image-guided Radiotherapy.
Alexander SE; McNair HA; Oelfke U; Huddart R; Murray J; Pathmanathan A; Patel P; Sritharan K; van As N; Tree AC
Clin Oncol (R Coll Radiol); 2022 Sep; 34(9):e383-e391. PubMed ID: 35469741
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance lymphography-guided selective high-dose lymph node irradiation in prostate cancer.
Meijer HJ; Debats OA; Kunze-Busch M; van Kollenburg P; Leer JW; Witjes JA; Kaanders JH; Barentsz JO; van Lin EN
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):175-83. PubMed ID: 21075555
[TBL] [Abstract][Full Text] [Related]
3. Prostatic displacement during extreme hypofractionated radiotherapy using volumetric modulated arc therapy (VMAT).
Gladwish A; Pang G; Cheung P; D'Alimonte L; Deabreu A; Loblaw A
Radiat Oncol; 2014 Nov; 9():262. PubMed ID: 25430973
[TBL] [Abstract][Full Text] [Related]
4. The impact of margin reduction on radiation dose distribution of ultra-hypofractionated prostate radiotherapy utilizing a 1.5-T MR-Linac.
Onal C; Efe E; Bozca R; Yavas C; Yavas G; Arslan G
J Appl Clin Med Phys; 2024 Jan; 25(1):e14179. PubMed ID: 38013636
[TBL] [Abstract][Full Text] [Related]
5. An unusual case of oedematous prostate volumetric changes observed over the course of radiotherapy on the MR linear accelerator.
Clough A; Bridge P; Hales R; McDaid L; Choudhury A; Eccles CL
J Med Imaging Radiat Sci; 2021 Mar; 52(1):147-151. PubMed ID: 33342695
[TBL] [Abstract][Full Text] [Related]
6. Long-term Tumor Control and Late Toxicity in Patients with Prostate Cancer Receiving Hypofractionated (2.2 Gy) Soft-tissue-matched Image-guided Intensity-modulated Radiotherapy.
Shimizu D; Yamazaki H; Nishimura T; Aibe N; Okabe H
Anticancer Res; 2017 Oct; 37(10):5829-5835. PubMed ID: 28982908
[TBL] [Abstract][Full Text] [Related]
7. The impact of the three degrees-of-freedom fiducial marker-based setup compared to soft tissue-based setup in hypofractionated intensity-modulated radiotherapy for prostate cancer.
Tanabe S; Utsunomiya S; Abe E; Sato H; Ohta A; Sakai H; Yamada T; Kaidu M; Aoyama H
J Appl Clin Med Phys; 2019 Jun; 20(6):53-59. PubMed ID: 31054217
[TBL] [Abstract][Full Text] [Related]
8. Image-guided intensity-modulated radiotherapy of prostate cancer: Analysis of interfractional errors and acute toxicity.
Rudat V; Nour A; Hammoud M; Alaradi A; Mohammed A
Strahlenther Onkol; 2016 Feb; 192(2):109-17. PubMed ID: 26545764
[TBL] [Abstract][Full Text] [Related]
9. Intra-fraction motion during extreme hypofractionated radiotherapy of the prostate using pre- and post-treatment imaging.
Quon H; Loblaw DA; Cheung PC; Holden L; Tang C; Pang G; Morton G; Mamedov A; Deabreu A
Clin Oncol (R Coll Radiol); 2012 Nov; 24(9):640-5. PubMed ID: 22226683
[TBL] [Abstract][Full Text] [Related]
10. Current status of intensity-modulated radiation therapy for prostate cancer: History, clinical results and future directions.
Hatano K; Tohyama N; Kodama T; Okabe N; Sakai M; Konoeda K
Int J Urol; 2019 Aug; 26(8):775-784. PubMed ID: 31115116
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of MRI-only treatment planning for proton therapy in brain and prostate cancers: Dose calculation accuracy in substitute CT images.
Koivula L; Wee L; Korhonen J
Med Phys; 2016 Aug; 43(8):4634. PubMed ID: 27487880
[TBL] [Abstract][Full Text] [Related]
12. Associations between volume changes and spatial dose metrics for the urinary bladder during local versus pelvic irradiation for prostate cancer.
Casares-Magaz O; Moiseenko V; Hopper A; Pettersson NJ; Thor M; Knopp R; Deasy JO; Muren LP; Einck J
Acta Oncol; 2017 Jun; 56(6):884-890. PubMed ID: 28401808
[TBL] [Abstract][Full Text] [Related]
13. [Changes in target volumes definition by using MRI for prostate bed radiotherapy planning--preliminary results].
Sefrová J; Paluska ; Odrázka K; Belobradek Z; Hoffmann P; Prosvic P; Brod'ák M; Louda M; Macingová Z; Vosmik M
Klin Onkol; 2010; 23(4):256-63. PubMed ID: 20806824
[TBL] [Abstract][Full Text] [Related]
14. A Monte-Carlo study to assess the effect of 1.5 T magnetic fields on the overall robustness of pencil-beam scanning proton radiotherapy plans for prostate cancer.
Kurz C; Landry G; Resch AF; Dedes G; Kamp F; Ganswindt U; Belka C; Raaymakers BW; Parodi K
Phys Med Biol; 2017 Oct; 62(21):8470-8482. PubMed ID: 29047455
[TBL] [Abstract][Full Text] [Related]
15. Cone beam CT-based dose accumulation and analysis of delivered dose to the dominant intraprostatic lesion in primary radiotherapy of prostate cancer.
Tamihardja J; Cirsi S; Kessler P; Razinskas G; Exner F; Richter A; Polat B; Flentje M
Radiat Oncol; 2021 Oct; 16(1):205. PubMed ID: 34702305
[TBL] [Abstract][Full Text] [Related]
16. Impact of image guidance on toxicity and tumour outcome in moderately hypofractionated external-beam radiotherapy for prostate cancer.
Jereczek-Fossa BA; Maucieri A; Marvaso G; Gandini S; Fodor C; Zerini D; Riva G; Alessandro O; Surgo A; Volpe S; Fanetti G; Arculeo S; Zerella MA; Parisi S; Maisonneuve P; Vavassori A; Cattani F; Cambria R; Garibaldi C; Starzyńska A; Musi G; De Cobelli O; Ferro M; Nolè F; Ciardo D; Orecchia R
Med Oncol; 2018 Nov; 36(1):9. PubMed ID: 30483899
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of online/offline image guidance/adaptation approaches for prostate cancer radiation therapy.
Qin A; Sun Y; Liang J; Yan D
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1026-33. PubMed ID: 25832693
[TBL] [Abstract][Full Text] [Related]
18. Dosimetric comparison of MR-linac-based IMRT and conventional VMAT treatment plans for prostate cancer.
Da Silva Mendes V; Nierer L; Li M; Corradini S; Reiner M; Kamp F; Niyazi M; Kurz C; Landry G; Belka C
Radiat Oncol; 2021 Jul; 16(1):133. PubMed ID: 34289868
[TBL] [Abstract][Full Text] [Related]
19. Prostate deformation during hypofractionated radiotherapy: an analysis of implanted fiducial marker displacement.
Knybel L; Cvek J; Blazek T; Binarova A; Parackova T; Resova K
Radiat Oncol; 2021 Dec; 16(1):235. PubMed ID: 34876173
[TBL] [Abstract][Full Text] [Related]
20. Does Interfraction Cone Beam Computed Tomography Improve Target Localization in Prostate Bed Radiotherapy?
Elakshar S; Tsui JMG; Kucharczyk MJ; Tomic N; Fawaz ZS; Bahoric B; Papayanatos J; Chaddad A; Niazi T
Technol Cancer Res Treat; 2019 Jan; 18():1533033819831962. PubMed ID: 30782085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
